Latest news

PCI Biotech to present at the World Vaccine Congress 2015

Posted on Apr 8, 2015

Lysaker, April 8, 2015 – PCI Biotech will be presenting at the World Vaccine Congress 2015 at Walter E. Washington Convention Center, Washington D.C. In its 15th year, World Vaccine Congress remains the industry’s definitive vaccine industry conference and exhibition for major vaccine players and their respective senior level representatives. The presentation “Photochemical internalisation (PCI) […]

PCI Biotech initiates pre-clinical research collaboration in siRNA therapeutics

Posted on Apr 7, 2015

Lysaker, 7 April 2015 – PCI Biotech (OSE: PCIB), a Norwegian cancer focused biopharmaceutical company, today announced that it is initiating a pre-clinical research collaboration with RXi Pharmaceuticals (NASDAQ: RXII), an American biotechnology company focused on discovering and developing innovative therapeutics, that address high-unmet medical needs primarily in the area of dermatology and ophthalmology. The […]

Annual Report 2014

Posted on Mar 24, 2015

Lysaker, 24 March 2015 – The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2014. The Board of Directors has decided to present the Annual Report 2014 to the ordinary general assembly scheduled to 12 May 2015. The Annual Report 2014 is Attached. PCIB ASA Annual Report 2014